SOCKNLEG Compression Stocking Kit : User Friendliness
SOCKNLEGZH
1 other identifier
interventional
47
1 country
1
Brief Summary
The investigators aim to evaluate the user friendliness of a newly designed leg compression stocking kit, the SOCKNLEG, compared to a standard leg compression stocking of the same compression strength, the SIGVARIS Cotton. The SOCKNLEG is not yet commercially available, whereas the SIGVARIS Cotton has been successfully commercialized for many years. After an initial screening visit, a computer generated list will allocate the participants in either the SOCKNLEG or the SIGVARIS Cotton group. All participants will try on both study stockings, in the order of their allocated group, and will rate their donning and doffing success with a questionnaire. The patients will then wear only the assigned study stocking of their allocated group, for a day and rate its comfort again at the end of the day. The donning and doffing success will also be rated by the study investigator. Leg volume measurements of the study leg will be taken at each visit to determine edema prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2017
CompletedStudy Start
First participant enrolled
January 10, 2018
CompletedFirst Posted
Study publicly available on registry
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2018
CompletedJune 27, 2019
June 1, 2019
6 months
December 15, 2017
June 26, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Number of patients who completely don the two investigated leg compression devices
through study completion, within 7 months
Secondary Outcomes (4)
Number of patients who completely doff the two investigated leg compression devices
through study completion, within 7 months
Patient evaluation of user friendliness
3 days
Measuring oedema prevention of the compression stockings by comparison of leg volume measurement at V4 to V3 and V4 to V2.
3 days
Time needed to don and doff the two investigated leg compression
3 days
Study Arms (2)
SOCKNLEG
EXPERIMENTALDonning and doffing success of the study stocking compared with both stockings, wearing of the study stocking for a day, standardized non invasive measurement to calculate leg volume of the study leg
SIGVARIS Cotton
ACTIVE COMPARATORDonning and doffing success of the study stocking compared with both stockings, wearing of the study stocking for a day, standardized non invasive measurement to calculate leg volume of the study leg
Interventions
Donning and doffing success compared with the two study stockings, wearing the assigned study stocking for a day, Patient Quesationnaire on donning and doffing success and wearing comfort of each study stocking
Eligibility Criteria
You may qualify if:
- Informed Consent as documented by signature
- Male or postmenopausal female patient, aged over 65 years of age
- Diagnosed venous insufficiency stage C3-C6 (according to CEAP (Clinical, Etiologic, Anatomic, Pathophysiologic) -classification for venous diseases)
You may not qualify if:
- Venous leg ulcer with a surface \>5cm2
- Peripheral artery disease (PAD) or media calcinosis (Ankle-Brachial-Index \<0.8 or \>1.3)
- Difference in brachial blood pressure \>20mmHg in both arms
- Suspected polyneuropathy with ≥4 sensible test areas, measured with the Semmes-Weinstein-Monofilament-Test
- Inability to reach the forefoot with their hands
- Inability to follow the procedures of the study
- Bed-ridden hospitalized patients who are not able to leave the bed or sit upright for a few consecutive hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, University Hospital of Zurich, Switzerland
Zurich, CH-8091, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Juerg Hafner, Prof.
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2017
First Posted
February 12, 2018
Study Start
January 10, 2018
Primary Completion
June 30, 2018
Study Completion
June 30, 2018
Last Updated
June 27, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share